Keunok Jung

Title: Keunok Jung: Innovator in Cytokine Research

Introduction

Keunok Jung is a prominent inventor based in Suwon, South Korea. He has made significant contributions to the field of biotechnology, particularly in the development of innovative cytokine therapies. With a total of 7 patents to his name, Jung's work is paving the way for advancements in medical treatments.

Latest Patents

Among his latest patents is the invention titled "Heterodimeric Fc-fused cytokine and pharmaceutical composition comprising the same." This invention focuses on a heterodimeric Fc-fused protein that includes a first and second Fc region of an immunoglobulin Fc pair. The protein is designed to enhance the formation of heterodimeric Fc, which has potential applications in therapeutic compositions. Another notable patent is for a "Human antibody having high affinity to human IL-4 receptor alpha." This invention provides an antibody that binds with high affinity to the human IL-4 receptor alpha chain, offering new avenues for treating inflammatory diseases.

Career Highlights

Keunok Jung is affiliated with the Ajou University Industry-Academic Cooperation Foundation, where he continues to engage in groundbreaking research. His work not only contributes to scientific knowledge but also has practical implications for developing new therapies.

Collaborations

Throughout his career, Jung has collaborated with notable colleagues, including Yong Sung Kim and Ji Hee Ha. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes.

Conclusion

Keunok Jung's contributions to cytokine research and his innovative patents highlight his role as a leading inventor in the biotechnology field. His work promises to impact the future of medical treatments significantly.